EcoDrugPlus

24-Dehydrocholesterol Reductase

Ensembl ID : ENSPPRG00000003617
Gene Symbol: DHCR24
4 Cross references
208 Possible Orthologues:

3-Hydroxy-3-Methylglutaryl-Coa Reductase

Ensembl ID : ENSPPRG00000008332
Gene Symbol: HMGCR
4 Cross references
270 Possible Orthologues:

3-Phosphoinositide Dependent Protein Kinase 1

Ensembl ID : ENSPPRG00000023885
Gene Symbol: PDPK1
4 Cross references
240 Possible Orthologues:

4-Hydroxyphenylpyruvate Dioxygenase

Ensembl ID : ENSPPRG00000014090
Gene Symbol: HPD
4 Cross references
204 Possible Orthologues:

40s Ribosomal Protein S12

Ensembl ID : ENSPPRG00000017292
Gene Symbol: LOC109264103
3 Cross references
146 Possible Orthologues:

40s Ribosomal Protein S15a-Like

Ensembl ID : ENSPPRG00000011337
Gene Symbol: LOC109256849
3 Cross references
69 Possible Orthologues:

5'-Nucleotidase Ecto

Ensembl ID : ENSPPRG00000014851
Gene Symbol: NT5E
4 Cross references
249 Possible Orthologues:

5-Hydroxytryptamine Receptor 1a

Ensembl ID : ENSPPRG00000021033
Gene Symbol: HTR1A
4 Cross references
147 Possible Orthologues:

5-Hydroxytryptamine Receptor 1b

Ensembl ID : ENSPPRG00000015888
Gene Symbol: HTR1B
4 Cross references
245 Possible Orthologues:

5-Hydroxytryptamine Receptor 1d

Ensembl ID : ENSPPRG00000021585
Gene Symbol: HTR1D
4 Cross references
67 Possible Orthologues:

5-Hydroxytryptamine Receptor 1e

Ensembl ID : ENSPPRG00000021350
Gene Symbol: HTR1E
4 Cross references
155 Possible Orthologues:

5-Hydroxytryptamine Receptor 1f

Ensembl ID : ENSPPRG00000011399
Gene Symbol: HTR1F
4 Cross references
145 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).